Jade Biosciences (JBIO) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Outperform | $47.00 from $45.00 | Aug 11, 2026 |
| BTIG | Maintained | Buy | $77.00 from $74.00 | Aug 10, 2026 |
| UBS | Initiated Coverage | Buy | $45.00 | Jun 15, 2026 |
| Wedbush | Maintained | Outperform | $45.00 from $34.00 | Jun 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $55.00 from $45.00 | Jun 1, 2026 |
| BTIG | Maintained | Buy | $74.00 from $39.00 | Jun 1, 2026 |
| BTIG | Maintained | Buy | $39.00 | May 27, 2026 |
| Wedbush | Maintained | Outperform | $34.00 from $24.00 | May 11, 2026 |
| Guggenheim | Maintained | Buy | $32.00 from $23.00 | May 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 from $35.00 | Apr 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $35.00 from $25.00 | Mar 25, 2026 |
| BTIG | Maintained | Buy | $39.00 from $28.00 | Mar 16, 2026 |
| Guggenheim | Maintained | Buy | $23.00 from $17.00 | Mar 11, 2026 |
| Wedbush | Maintained | Outperform | $24.00 | Mar 9, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $25.00 | Jan 7, 2026 |
| Clear Street | Initiated Coverage | Buy | $25.00 | Nov 25, 2025 |
| Guggenheim | Maintained | Buy | $17.00 from $14.00 | Nov 18, 2025 |
| BTIG | Initiated Coverage | Buy | $28.00 | Oct 9, 2025 |
| Wedbush | Maintained | Outperform | $18.00 from $17.00 | Aug 14, 2025 |
| Guggenheim | Upgraded | Neutral → Buy | $14.00 | Jun 16, 2025 |
Frequently asked questions
What is the price target for JBIO stock?
The average 12-month analyst price target for Jade Biosciences (JBIO) is $56.00, with a high estimate of $77.00 and a low of $45.00, across 4 analysts.
Is JBIO a buy, sell, or hold?
Analysts covering Jade Biosciences currently average a Buy rating: 11 buy, 0 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for JBIO?
The average price target of $56.00 implies 162.17% upside from the last price of $21.36.
What is the latest analyst rating on JBIO?
On Aug 11, 2026, Wedbush maintained Jade Biosciences at Outperform with a price target of $47.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.